Accelerated hematopoietic recovery with angiotensin-(1–7) after total body radiation

References

• Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Menard J. 1996. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. Journal of Clinical Investigation 97:839–844.
   PubMed Web of Science ®Google Scholar
• Barshishat-Kupper M, Mungunsukh O, Tipton AJ, McCart EA, Panganiban RA, Davis TA, Landauer MR, Day RM. 2011. Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation. Experimental Hematology. 39:293–304.
   PubMed Web of Science ®Google Scholar
• Brown AP, Chung EJ, Urick ME, Shield WP 3rd, Sowers AL, Thetford A, Shankavaram UT, Mitchell JB, Citrin DE. 2010. Evaluation of the fullerene compound DF-1 as a radiation protector. Radiation Oncology 5:34.
   PubMed Web of Science ®Google Scholar
• Charrier S, Michaud A, Badaoui S, Giroux S, Ezan E, Sainteny F, Corvol P, Vainchenker W. 2004. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood 104:978–985.
   PubMed Web of Science ®Google Scholar
• Chisi JE, Briscoe CV, Ezan E, Genet R, Riches AC, Wdzieczak-Bakala J. 2000. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. British Journal of Haematology 109:563–570.
   PubMed Web of Science ®Google Scholar
• Chisi JE, Wdzieczak-Bakala J, Thierry J, Briscoe CV, Riches AC. 1999. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells 17:339–344.
   PubMed Web of Science ®Google Scholar
• Davis TA, Landauer MR, Mog SR, Barshishat-Kupper M, Zins SR, Amare MF, Day RM. 2010. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Experimental Hematology 38:270–281.
   PubMed Web of Science ®Google Scholar
• Day RM, Barshishat-Kupper M, Mog SR, McCart EA, Prasanna PG, Davis TA, Landauer MR. 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. Journal of Radiation Research (Tokyo) 49:361–372.
   PubMed Web of Science ®Google Scholar
• Dicarlo AL, Poncz M, Cassatt DR, Shah JR, Czarniecki CW, Maidment BW. 2011. Medical countermeasures for platelet regeneration after radiation exposure. Radiation Research 176:134–137.
   PubMed Web of Science ®Google Scholar
• Ellefson DD, diZerega GS, Espinoza T, Roda N, Maldonado S, Rodgers KE. 2004. Synergistic effects of co-administration of angiotensin 1–7 and Neupogen on hematopoietic recovery in mice. Cancer Chemotherapy Pharmacology 53:15–24.
   PubMed Web of Science ®Google Scholar
• Guinan EC, Barbon CM, Kalish LA, Parmar K, Kutok J, Mancuso CJ, Stoler-Barak L, Suter LA, Russel JD, Palmer CD, Gallington LC, Voskertchian A, Vergilio J-A, Cole G, Zhu K, D'Andrea A, Soiffer R, Weiss JP, Levy O. 2011. Bactericidal/Permeability-Increasing Protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death. Science Translational Medicine 3: 111–118.
   Web of Science ®Google Scholar
• Haznedaroglu IC, Ozturk MA. 2003. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. International Journal of Biochemistry and Cell Biology 35: 867–880.
   PubMed Web of Science ®Google Scholar
• Heringer-Walther S, Eckert K, Schumacher SM, Uharek L, Wulf-Goldenberg A, Gembardt F, Fichtner I, Schultheiss HP, Rodgers K, Walther T. 2009. Angiotensin-(1–7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 94:857–860.
   PubMed Web of Science ®Google Scholar
• Hosseinimehr SJ. 2007. Trends in the development of radioprotective agents. Drug Discovery Today 12:794–805.
   PubMed Web of Science ®Google Scholar
• Iyer SN, Ferrario CM, Chappell MC. 1998. Angiotensin-(1–7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 31:356–361.
   PubMed Web of Science ®Google Scholar
• Jackson CW. 1973. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 42:413–421.
   PubMed Web of Science ®Google Scholar
• Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, Smith I, Peault B, Tavian M, Simmons PJ. 2008. Angiotensin converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal and adult hematopoietic tissues. Blood 111: 4055–4063.
   PubMed Web of Science ®Google Scholar
• Landauer MR, Srinivasan V, Seed TM. 2003. Genistein treatment protects mice from ionizing radiation injury. Journal of Applied Toxicology 23:379–385.
   PubMed Web of Science ®Google Scholar
• Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, Wolfe LF, Brizio-Molteni L, Veno P. 2000. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin type II type 1 receptor blocker. International Journal of Radiation Biology 76:523–532.
   PubMed Web of Science ®Google Scholar
• Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. 1997. Angiotensin II stimulates proliferation of normal early erythroid progenitors. Journal of Clinical Investigation 100:2310–2314.
   PubMed Web of Science ®Google Scholar
• Peng R, Li Y, Brezner K, Litherland S, Clare-Salzler MJ. 2003. Abnormal peripheral blood dendritic cell populations in type 1 diabetes. Annals of New York Academy of Sciences 1005:222–225.
   PubMed Web of Science ®Google Scholar
• Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB. 2004. Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. Journal of Renin Angiotensin Aldosterone System 5:176–182.
   PubMed Web of Science ®Google Scholar
• Rodgers K, Xiong S, DiZerega GS. 2003. Effect of angiotensin II and angiotensin(1–7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemotherapy and Pharmacology 51: 97–106.
   PubMed Web of Science ®Google Scholar
• Rodgers K, Xiong S, Felix J, Roda N, Espinoza T, Maldonado S, Dizerega G. 2001. Development of angiotensin (1–7) as an agent to accelerate dermal repair. Wound Repair Regeneration 9:238–247.
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Oliver J, diZerega GS. 2006. Phase I/II dose escalation study of angiotensin 1–7 [A(1–7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemotherapy Pharmacology 57:559–568.
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Xiong S, diZerega GS. 2002. Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemotherapy Pharmacology 49:403–411.
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Xiong S, Steer R, diZerega GS. 2000. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18: 287–294.
   PubMed Web of Science ®Google Scholar
• Roks AJ, Rodgers K, Walther T. 2011. Effects of renin angiotensin system on vasculogenesis-related progenitor cells. Current Opinion in Pharmacology 11:162–174.
   PubMed Web of Science ®Google Scholar
• Rousseau-Plasse A, Wdzieczak-Bakala J, Lenfant M, Ezan E, Genet R, Robinson S, Briscoe T, Melville J, Riches A. 1998. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. Experimental Hematology 26:1074–1079.
   PubMed Web of Science ®Google Scholar
• Shen XZ, Bernstein KE. 2011. The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle 10:1363–1369.
   PubMed Web of Science ®Google Scholar
• Slukvin II. 2009. Renin angiotensin system and hemangioblast development from human embryonic stem cells. Expert Review in Hematology 2:137–143.
   PubMed Web of Science ®Google Scholar
• Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, Ferrario CM. 2004. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. British Journal of Haematology 126:120–126.
   PubMed Web of Science ®Google Scholar
• Tavian M, Biasch K, Sinka L, Vallet J, Peault B. 2010. Embryonic origin of human hematopoiesis. International Journal of Developmental Biology 54:1061–1065.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qian C, Roks AJ, Westermann D, Schumacher SM, Escher F, Schoemaker RG, Reudelhuber TL, van Gilst WH, Schultheiss HP, Tschope C, Walther T. 2010. Circulating rather than cardiac angiotensin-(1–7) stimulates cardioprotection after myocardial infarction. Circulation Heart Failure 3:286–293.
   PubMed Web of Science ®Google Scholar
• Ward WF, Kim, YT, Molteni A, Solliday NH. 1988. Radiation-induced pulmonary endothelial dysfunction in rats: Modification by an inhibitor of angiotensin converting enzyme. International Journal of Radiation Oncology, Biology and Physiology 15:135–140.
   PubMed Web of Science ®Google Scholar
• Ward WF, Molteni A, Kim YT, Ts'ao C. 1989. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifiers of radiation-induced pulmonary endothelial dysfunction in rats. British Journal of Radiation 62:348–354.
   PubMed Web of Science ®Google Scholar
• Wei L, Alhenc-Gelas F, Corvol P, Clauser E. 1991. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. Journal of Biological Chemistry 266:9002–9008.
   PubMed Web of Science ®Google Scholar
• Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M, Peault B. 2008. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 112:3601–3614.
   PubMed Web of Science ®Google Scholar